A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia

AS Chappell, G Littlejohn, DK Kajdasz… - The clinical journal …, 2009 - journals.lww.com
Objectives Evaluate the efficacy and safety of duloxetine at doses up to 120 mg once daily in
patients with fibromyalgia. Methods This was a phase 3, 60-week study, which included an 8 …
被引用次数：89 相关文章

[引用][C] A 1-year Safety and Efficacy Study of Duloxetine in Patients With Fibromyalgia

AS CHAPPELL, G LITTLEJOHN… - The Clinical journal …, 2009 - pascal-francis.inist.fr
A 1-year Safety and Efficacy Study of Duloxetine in Patients With Fibromyalgia CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …

A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia.

AS Chappell, G Littlejohn, DK Kajdasz… - The Clinical Journal …, 2009 - europepmc.org
Objectives Evaluate the efficacy and safety of duloxetine at doses up to 120 mg once daily in
patients with fibromyalgia. Methods This was a phase 3, 60-week study, which included an 8 …

A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia

AS Chappell, G Littlejohn, DK Kajdasz, M Scheinberg… - 2009 - pubmed.ncbi.nlm.nih.gov
Objectives Evaluate the efficacy and safety of duloxetine at doses up to 120 mg once daily in
patients with fibromyalgia. Methods This was a phase 3, 60-week study, which included an 8 …

A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia

AS Chappell, GO Littlejohn… - The Clinical Journal …, 2009 - research.monash.edu
Objectives: Evaluate the efficacy and safety of duloxetine at doses up to 120mg once daily in
patients with fibromyalgia. Methods: This was a phase 3, 60-week study, which included an …

[引用][C] A 1-year Safety and Efficacy Study of Duloxetine in Patients With Fibromyalgia

AS CHAPPELL, G LITTLEJOHN… - … Clinical journal of …, 2009 - Lippincott Williams & Wilkins